#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Antibiotics are medicines that fight bacterial infections .
2-1	16-27	Antibiotics	substance	new	coref	2-3[3_0]
2-2	28-31	are	_	_	_	_
2-3	32-41	medicines	substance[3]	giv[3]	coref	6-47[0_3]
2-4	42-46	that	substance[3]	giv[3]	_	_
2-5	47-52	fight	substance[3]	giv[3]	_	_
2-6	53-62	bacterial	substance[3]|object[4]	giv[3]|new[4]	ana	3-1[0_4]
2-7	63-73	infections	substance[3]|object[4]	giv[3]|new[4]	_	_
2-8	74-75	.	_	_	_	_

#Text=They can save lives if they are used correctly , but nowadays antibiotic resistance has become a real problem .
3-1	76-80	They	object	giv	ana	3-6
3-2	81-84	can	_	_	_	_
3-3	85-89	save	_	_	_	_
3-4	90-95	lives	abstract	new	_	_
3-5	96-98	if	_	_	_	_
3-6	99-103	they	object	giv	_	_
3-7	104-107	are	_	_	_	_
3-8	108-112	used	_	_	_	_
3-9	113-122	correctly	_	_	_	_
3-10	123-124	,	_	_	_	_
3-11	125-128	but	_	_	_	_
3-12	129-137	nowadays	_	_	_	_
3-13	138-148	antibiotic	abstract[8]	new[8]	coref	6-4[24_8]
3-14	149-159	resistance	abstract[8]	new[8]	_	_
3-15	160-163	has	_	_	_	_
3-16	164-170	become	_	_	_	_
3-17	171-172	a	_	_	_	_
3-18	173-177	real	_	_	_	_
3-19	178-185	problem	_	_	_	_
3-20	186-187	.	_	_	_	_

#Text=Infections by resistant microorganisms do not respond to treatment , so the duration of the disease is prolonged , and the risk of death increases .
4-1	188-198	Infections	abstract[9]	new[9]	_	_
4-2	199-201	by	abstract[9]	new[9]	_	_
4-3	202-211	resistant	abstract[9]|animal[10]	new[9]|new[10]	coref	5-28[21_10]
4-4	212-226	microorganisms	abstract[9]|animal[10]	new[9]|new[10]	_	_
4-5	227-229	do	_	_	_	_
4-6	230-233	not	_	_	_	_
4-7	234-241	respond	_	_	_	_
4-8	242-244	to	_	_	_	_
4-9	245-254	treatment	event	new	coref	5-4[16_0]
4-10	255-256	,	_	_	_	_
4-11	257-259	so	_	_	_	_
4-12	260-263	the	time[12]	new[12]	_	_
4-13	264-272	duration	time[12]	new[12]	_	_
4-14	273-275	of	time[12]	new[12]	_	_
4-15	276-279	the	time[12]|abstract[13]	new[12]|new[13]	_	_
4-16	280-287	disease	time[12]|abstract[13]	new[12]|new[13]	_	_
4-17	288-290	is	_	_	_	_
4-18	291-300	prolonged	_	_	_	_
4-19	301-302	,	_	_	_	_
4-20	303-306	and	_	_	_	_
4-21	307-310	the	abstract[14]	new[14]	_	_
4-22	311-315	risk	abstract[14]	new[14]	_	_
4-23	316-318	of	abstract[14]	new[14]	_	_
4-24	319-324	death	abstract[14]|event	new[14]|new	_	_
4-25	325-334	increases	_	_	_	_
4-26	335-336	.	_	_	_	_

#Text=Moreover , if the treatment fails or if the response to treatment is slow , the patient is contagious for longer , which increases the likelihood of resistant microorganisms being transmitted to other people .
5-1	337-345	Moreover	_	_	_	_
5-2	346-347	,	_	_	_	_
5-3	348-350	if	_	_	_	_
5-4	351-354	the	event[16]	giv[16]	coref	5-12[0_16]
5-5	355-364	treatment	event[16]	giv[16]	_	_
5-6	365-370	fails	_	_	_	_
5-7	371-373	or	_	_	_	_
5-8	374-376	if	_	_	_	_
5-9	377-380	the	event[17]	new[17]	_	_
5-10	381-389	response	event[17]	new[17]	_	_
5-11	390-392	to	event[17]	new[17]	_	_
5-12	393-402	treatment	event[17]|event	new[17]|giv	_	_
5-13	403-405	is	_	_	_	_
5-14	406-410	slow	_	_	_	_
5-15	411-412	,	_	_	_	_
5-16	413-416	the	person[19]	new[19]	coref	9-37[78_19]
5-17	417-424	patient	person[19]	new[19]	_	_
5-18	425-427	is	_	_	_	_
5-19	428-438	contagious	_	_	_	_
5-20	439-442	for	_	_	_	_
5-21	443-449	longer	_	_	_	_
5-22	450-451	,	_	_	_	_
5-23	452-457	which	_	_	_	_
5-24	458-467	increases	_	_	_	_
5-25	468-471	the	abstract[20]	new[20]	_	_
5-26	472-482	likelihood	abstract[20]	new[20]	_	_
5-27	483-485	of	abstract[20]	new[20]	_	_
5-28	486-495	resistant	abstract[20]|animal[21]	new[20]|giv[21]	_	_
5-29	496-510	microorganisms	abstract[20]|animal[21]	new[20]|giv[21]	_	_
5-30	511-516	being	abstract[20]	new[20]	_	_
5-31	517-528	transmitted	abstract[20]	new[20]	_	_
5-32	529-531	to	abstract[20]	new[20]	_	_
5-33	532-537	other	abstract[20]|person[22]	new[20]|new[22]	_	_
5-34	538-544	people	abstract[20]|person[22]	new[20]|new[22]	_	_
5-35	545-546	.	_	_	_	_

#Text=The emergence of antibiotic resistance is a natural biological phenomenon , and even though numerous factors have been identified as the cause of this , such as clustering and overcrowding or increased elderly population , one of the most important factors is the inadequate use of antibiotics , a very worrying situation especially for healthcare professionals with high rate of antibiotic prescription such as primary care dentists .
6-1	547-550	The	abstract[23]	new[23]	coref	6-7[25_23]
6-2	551-560	emergence	abstract[23]	new[23]	_	_
6-3	561-563	of	abstract[23]	new[23]	_	_
6-4	564-574	antibiotic	abstract[23]|abstract[24]	new[23]|giv[24]	coref	11-19[105_24]
6-5	575-585	resistance	abstract[23]|abstract[24]	new[23]|giv[24]	_	_
6-6	586-588	is	_	_	_	_
6-7	589-590	a	abstract[25]|abstract[26]	giv[25]|giv[26]	coref	6-7[26_25]
6-8	591-598	natural	abstract[25]|abstract[26]	giv[25]|giv[26]	_	_
6-9	599-609	biological	abstract[25]|abstract[26]	giv[25]|giv[26]	_	_
6-10	610-620	phenomenon	abstract[25]|abstract[26]	giv[25]|giv[26]	_	_
6-11	621-622	,	abstract[26]	giv[26]	_	_
6-12	623-626	and	abstract[26]	giv[26]	_	_
6-13	627-631	even	abstract[26]	giv[26]	_	_
6-14	632-638	though	abstract[26]	giv[26]	_	_
6-15	639-647	numerous	abstract[26]|abstract[27]	giv[26]|new[27]	coref	6-38[33_27]
6-16	648-655	factors	abstract[26]|abstract[27]	giv[26]|new[27]	_	_
6-17	656-660	have	abstract[26]	giv[26]	_	_
6-18	661-665	been	abstract[26]	giv[26]	_	_
6-19	666-676	identified	abstract[26]	giv[26]	_	_
6-20	677-679	as	abstract[26]	giv[26]	_	_
6-21	680-683	the	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-22	684-689	cause	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-23	690-692	of	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-24	693-697	this	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-25	698-699	,	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-26	700-704	such	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-27	705-707	as	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-28	708-718	clustering	abstract[26]|abstract[28]|abstract	giv[26]|new[28]|new	_	_
6-29	719-722	and	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-30	723-735	overcrowding	abstract[26]|abstract[28]|abstract	giv[26]|new[28]|new	_	_
6-31	736-738	or	abstract[26]|abstract[28]	giv[26]|new[28]	_	_
6-32	739-748	increased	abstract[26]|abstract[28]|person[31]	giv[26]|new[28]|new[31]	_	_
6-33	749-756	elderly	abstract[26]|abstract[28]|person[31]	giv[26]|new[28]|new[31]	_	_
6-34	757-767	population	abstract[26]|abstract[28]|person[31]	giv[26]|new[28]|new[31]	_	_
6-35	768-769	,	abstract[26]	giv[26]	_	_
6-36	770-773	one	abstract[26]|event[32]	giv[26]|new[32]	coref	6-43[34_32]
6-37	774-776	of	abstract[26]|event[32]	giv[26]|new[32]	_	_
6-38	777-780	the	abstract[26]|event[32]|abstract[33]	giv[26]|new[32]|giv[33]	_	_
6-39	781-785	most	abstract[26]|event[32]|abstract[33]	giv[26]|new[32]|giv[33]	_	_
6-40	786-795	important	abstract[26]|event[32]|abstract[33]	giv[26]|new[32]|giv[33]	_	_
6-41	796-803	factors	abstract[26]|event[32]|abstract[33]	giv[26]|new[32]|giv[33]	_	_
6-42	804-806	is	abstract[26]	giv[26]	_	_
6-43	807-810	the	abstract[26]|event[34]	giv[26]|giv[34]	coref	9-1[66_34]
6-44	811-821	inadequate	abstract[26]|event[34]	giv[26]|giv[34]	_	_
6-45	822-825	use	abstract[26]|event[34]	giv[26]|giv[34]	_	_
6-46	826-828	of	abstract[26]|event[34]	giv[26]|giv[34]	_	_
6-47	829-840	antibiotics	abstract[26]|event[34]|substance	giv[26]|giv[34]|giv	coref	7-14
6-48	841-842	,	_	_	_	_
6-49	843-844	a	abstract[36]	new[36]	coref	10-35[94_36]
6-50	845-849	very	abstract[36]	new[36]	_	_
6-51	850-858	worrying	abstract[36]	new[36]	_	_
6-52	859-868	situation	abstract[36]	new[36]	_	_
6-53	869-879	especially	abstract[36]|person[38]	new[36]|new[38]	_	_
6-54	880-883	for	abstract[36]|person[38]	new[36]|new[38]	_	_
6-55	884-894	healthcare	abstract[36]|organization|person[38]	new[36]|new|new[38]	coref	9-34
6-56	895-908	professionals	abstract[36]|person[38]	new[36]|new[38]	_	_
6-57	909-913	with	abstract[36]|person[38]	new[36]|new[38]	_	_
6-58	914-918	high	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
6-59	919-923	rate	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
6-60	924-926	of	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
6-61	927-937	antibiotic	abstract[36]|person[38]|abstract[39]|abstract[40]	new[36]|new[38]|new[39]|new[40]	coref	7-16[47_40]
6-62	938-950	prescription	abstract[36]|person[38]|abstract[39]|abstract[40]	new[36]|new[38]|new[39]|new[40]	_	_
6-63	951-955	such	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
6-64	956-958	as	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
6-65	959-966	primary	abstract[36]|person[38]|abstract[39]|abstract[41]|person[42]	new[36]|new[38]|new[39]|new[41]|new[42]	_	_
6-66	967-971	care	abstract[36]|person[38]|abstract[39]|abstract[41]|person[42]	new[36]|new[38]|new[39]|new[41]|new[42]	_	_
6-67	972-980	dentists	abstract[36]|person[38]|abstract[39]|person[42]	new[36]|new[38]|new[39]|new[42]	_	_
6-68	981-982	.	_	_	_	_

#Text=According to the World Health Organization ( WHO ) , inadequate use of antibiotics includes the prescription of inappropriate antibiotics for a brief time , in low or insufficient doses and/or for diseases for which they are not indicated ; likewise , excessive therapeutic dosage regimens are also considered inadequate uses of antibiotics .
7-1	983-992	According	_	_	_	_
7-2	993-995	to	_	_	_	_
7-3	996-999	the	organization[43]	new[43]	appos	7-8[0_43]
7-4	1000-1005	World	organization[43]	new[43]	_	_
7-5	1006-1012	Health	organization[43]	new[43]	_	_
7-6	1013-1025	Organization	organization[43]	new[43]	_	_
7-7	1026-1027	(	_	_	_	_
7-8	1028-1031	WHO	organization	giv	_	_
7-9	1032-1033	)	_	_	_	_
7-10	1034-1035	,	_	_	_	_
7-11	1036-1046	inadequate	event[45]	new[45]	_	_
7-12	1047-1050	use	event[45]	new[45]	_	_
7-13	1051-1053	of	event[45]	new[45]	_	_
7-14	1054-1065	antibiotics	event[45]|substance	new[45]|giv	coref	7-19[48_0]
7-15	1066-1074	includes	_	_	_	_
7-16	1075-1078	the	abstract[47]	giv[47]	coref	8-23[65_47]
7-17	1079-1091	prescription	abstract[47]	giv[47]	_	_
7-18	1092-1094	of	abstract[47]	giv[47]	_	_
7-19	1095-1108	inappropriate	abstract[47]|substance[48]	giv[47]|giv[48]	coref	7-53[0_48]
7-20	1109-1120	antibiotics	abstract[47]|substance[48]	giv[47]|giv[48]	_	_
7-21	1121-1124	for	abstract[47]|substance[48]	giv[47]|giv[48]	_	_
7-22	1125-1126	a	abstract[47]|substance[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
7-23	1127-1132	brief	abstract[47]|substance[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
7-24	1133-1137	time	abstract[47]|substance[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
7-25	1138-1139	,	abstract[47]	giv[47]	_	_
7-26	1140-1142	in	abstract[47]	giv[47]	_	_
7-27	1143-1146	low	abstract[47]|abstract[50]	giv[47]|new[50]	_	_
7-28	1147-1149	or	abstract[47]|abstract[50]	giv[47]|new[50]	_	_
7-29	1150-1162	insufficient	abstract[47]|abstract[50]	giv[47]|new[50]	_	_
7-30	1163-1168	doses	abstract[47]|abstract[50]	giv[47]|new[50]	_	_
7-31	1169-1175	and/or	_	_	_	_
7-32	1176-1179	for	_	_	_	_
7-33	1180-1188	diseases	abstract[51]	new[51]	ana	7-36[0_51]
7-34	1189-1192	for	abstract[51]	new[51]	_	_
7-35	1193-1198	which	abstract[51]	new[51]	_	_
7-36	1199-1203	they	abstract[51]|abstract	new[51]|giv	coref	11-16[103_0]
7-37	1204-1207	are	abstract[51]	new[51]	_	_
7-38	1208-1211	not	abstract[51]	new[51]	_	_
7-39	1212-1221	indicated	abstract[51]	new[51]	_	_
7-40	1222-1223	;	_	_	_	_
7-41	1224-1232	likewise	_	_	_	_
7-42	1233-1234	,	_	_	_	_
7-43	1235-1244	excessive	abstract[54]	new[54]	_	_
7-44	1245-1256	therapeutic	abstract[54]	new[54]	_	_
7-45	1257-1263	dosage	substance|abstract[54]	new|new[54]	_	_
7-46	1264-1272	regimens	abstract[54]	new[54]	_	_
7-47	1273-1276	are	_	_	_	_
7-48	1277-1281	also	_	_	_	_
7-49	1282-1292	considered	_	_	_	_
7-50	1293-1303	inadequate	abstract[55]	new[55]	_	_
7-51	1304-1308	uses	abstract[55]	new[55]	_	_
7-52	1309-1311	of	abstract[55]	new[55]	_	_
7-53	1312-1323	antibiotics	abstract[55]|substance	new[55]|giv	coref	8-11
7-54	1324-1325	.	_	_	_	_

#Text=In the specific case of Spain , the consumption of antibiotics for outpatients is above the European average , and in hospitals their prescription is increasing .
8-1	1326-1328	In	_	_	_	_
8-2	1329-1332	the	abstract[57]	new[57]	_	_
8-3	1333-1341	specific	abstract[57]	new[57]	_	_
8-4	1342-1346	case	abstract[57]	new[57]	_	_
8-5	1347-1349	of	abstract[57]	new[57]	_	_
8-6	1350-1355	Spain	abstract[57]|place	new[57]|new	_	_
8-7	1356-1357	,	_	_	_	_
8-8	1358-1361	the	event[59]	new[59]	_	_
8-9	1362-1373	consumption	event[59]	new[59]	_	_
8-10	1374-1376	of	event[59]	new[59]	_	_
8-11	1377-1388	antibiotics	event[59]|substance	new[59]|giv	ana	8-23
8-12	1389-1392	for	event[59]	new[59]	_	_
8-13	1393-1404	outpatients	event[59]|person	new[59]|new	_	_
8-14	1405-1407	is	_	_	_	_
8-15	1408-1413	above	_	_	_	_
8-16	1414-1417	the	abstract[62]	new[62]	_	_
8-17	1418-1426	European	abstract[62]	new[62]	_	_
8-18	1427-1434	average	abstract[62]	new[62]	_	_
8-19	1435-1436	,	_	_	_	_
8-20	1437-1440	and	_	_	_	_
8-21	1441-1443	in	_	_	_	_
8-22	1444-1453	hospitals	place	new	_	_
8-23	1454-1459	their	substance|abstract[65]	giv|giv[65]	coref	9-5
8-24	1460-1472	prescription	abstract[65]	giv[65]	_	_
8-25	1473-1475	is	_	_	_	_
8-26	1476-1486	increasing	_	_	_	_
8-27	1487-1488	.	_	_	_	_

#Text=The inadequate use of antibiotics can be encouraged by self-medication , by the implementation of permissive policies in terms of regulation of the use of these drugs , by the relationship between the healthcare professional and the patient or by the knowledge and attitudes that one has towards them .
9-1	1489-1492	The	event[66]	giv[66]	ana	9-46[0_66]
9-2	1493-1503	inadequate	event[66]	giv[66]	_	_
9-3	1504-1507	use	event[66]	giv[66]	_	_
9-4	1508-1510	of	event[66]	giv[66]	_	_
9-5	1511-1522	antibiotics	event[66]|substance	giv[66]|giv	coref	9-26[73_0]
9-6	1523-1526	can	_	_	_	_
9-7	1527-1529	be	_	_	_	_
9-8	1530-1540	encouraged	_	_	_	_
9-9	1541-1543	by	_	_	_	_
9-10	1544-1559	self-medication	abstract	new	_	_
9-11	1560-1561	,	_	_	_	_
9-12	1562-1564	by	_	_	_	_
9-13	1565-1568	the	event[69]	new[69]	_	_
9-14	1569-1583	implementation	event[69]	new[69]	_	_
9-15	1584-1586	of	event[69]	new[69]	_	_
9-16	1587-1597	permissive	event[69]|abstract[70]	new[69]|new[70]	_	_
9-17	1598-1606	policies	event[69]|abstract[70]	new[69]|new[70]	_	_
9-18	1607-1609	in	event[69]|abstract[70]	new[69]|new[70]	_	_
9-19	1610-1615	terms	event[69]|abstract[70]	new[69]|new[70]	_	_
9-20	1616-1618	of	event[69]|abstract[70]	new[69]|new[70]	_	_
9-21	1619-1629	regulation	event[69]|abstract[70]|abstract[71]	new[69]|new[70]|new[71]	_	_
9-22	1630-1632	of	event[69]|abstract[70]|abstract[71]	new[69]|new[70]|new[71]	_	_
9-23	1633-1636	the	event[69]|abstract[70]|abstract[71]|event[72]	new[69]|new[70]|new[71]|new[72]	_	_
9-24	1637-1640	use	event[69]|abstract[70]|abstract[71]|event[72]	new[69]|new[70]|new[71]|new[72]	_	_
9-25	1641-1643	of	event[69]|abstract[70]|abstract[71]|event[72]	new[69]|new[70]|new[71]|new[72]	_	_
9-26	1644-1649	these	event[69]|abstract[70]|abstract[71]|event[72]|substance[73]	new[69]|new[70]|new[71]|new[72]|giv[73]	coref	10-17[0_73]
9-27	1650-1655	drugs	event[69]|abstract[70]|abstract[71]|event[72]|substance[73]	new[69]|new[70]|new[71]|new[72]|giv[73]	_	_
9-28	1656-1657	,	_	_	_	_
9-29	1658-1660	by	_	_	_	_
9-30	1661-1664	the	abstract[74]	new[74]	_	_
9-31	1665-1677	relationship	abstract[74]	new[74]	_	_
9-32	1678-1685	between	abstract[74]	new[74]	_	_
9-33	1686-1689	the	abstract[74]|person[76]|person[77]	new[74]|new[76]|new[77]	ana	9-49[0_77]
9-34	1690-1700	healthcare	abstract[74]|organization|person[76]|person[77]	new[74]|giv|new[76]|new[77]	coref	11-12
9-35	1701-1713	professional	abstract[74]|person[76]|person[77]	new[74]|new[76]|new[77]	_	_
9-36	1714-1717	and	abstract[74]|person[77]	new[74]|new[77]	_	_
9-37	1718-1721	the	abstract[74]|person[77]|person[78]	new[74]|new[77]|giv[78]	_	_
9-38	1722-1729	patient	abstract[74]|person[77]|person[78]	new[74]|new[77]|giv[78]	_	_
9-39	1730-1732	or	_	_	_	_
9-40	1733-1735	by	_	_	_	_
9-41	1736-1739	the	abstract[79]|abstract[80]	new[79]|new[80]	coref|coref	10-10[86_79]|10-10[87_80]
9-42	1740-1749	knowledge	abstract[79]|abstract[80]	new[79]|new[80]	_	_
9-43	1750-1753	and	abstract[80]	new[80]	_	_
9-44	1754-1763	attitudes	abstract[80]|abstract[81]	new[80]|new[81]	_	_
9-45	1764-1768	that	abstract[80]|abstract[81]	new[80]|new[81]	_	_
9-46	1769-1772	one	abstract[80]|abstract[81]|event	new[80]|new[81]|giv	_	_
9-47	1773-1776	has	abstract[80]|abstract[81]	new[80]|new[81]	_	_
9-48	1777-1784	towards	abstract[80]|abstract[81]	new[80]|new[81]	_	_
9-49	1785-1789	them	abstract[80]|abstract[81]|person	new[80]|new[81]|giv	_	_
9-50	1790-1791	.	_	_	_	_

#Text=Regarding the latter , while it is true that a poor knowledge or negative attitude towards antibiotics leads inevitably to bad clinical practice , practical skills are not always a reflection of knowledge , a situation known as “ theory – practice gap ” .
10-1	1792-1801	Regarding	_	_	_	_
10-2	1802-1805	the	abstract[84]	new[84]	ana	10-6[0_84]
10-3	1806-1812	latter	abstract[84]	new[84]	_	_
10-4	1813-1814	,	_	_	_	_
10-5	1815-1820	while	_	_	_	_
10-6	1821-1823	it	abstract	giv	_	_
10-7	1824-1826	is	_	_	_	_
10-8	1827-1831	true	_	_	_	_
10-9	1832-1836	that	_	_	_	_
10-10	1837-1838	a	abstract[86]|abstract[87]	giv[86]|giv[87]	coref|coref	10-33[0_86]|13-12[136_87]
10-11	1839-1843	poor	abstract[86]|abstract[87]	giv[86]|giv[87]	_	_
10-12	1844-1853	knowledge	abstract[86]|abstract[87]	giv[86]|giv[87]	_	_
10-13	1854-1856	or	abstract[87]	giv[87]	_	_
10-14	1857-1865	negative	abstract[87]|abstract[88]	giv[87]|new[88]	_	_
10-15	1866-1874	attitude	abstract[87]|abstract[88]	giv[87]|new[88]	_	_
10-16	1875-1882	towards	abstract[87]|abstract[88]	giv[87]|new[88]	_	_
10-17	1883-1894	antibiotics	abstract[87]|abstract[88]|substance	giv[87]|new[88]|giv	coref	11-25
10-18	1895-1900	leads	_	_	_	_
10-19	1901-1911	inevitably	_	_	_	_
10-20	1912-1914	to	_	_	_	_
10-21	1915-1918	bad	abstract[90]	new[90]	coref	10-42[0_90]
10-22	1919-1927	clinical	abstract[90]	new[90]	_	_
10-23	1928-1936	practice	abstract[90]	new[90]	_	_
10-24	1937-1938	,	_	_	_	_
10-25	1939-1948	practical	abstract[91]	new[91]	_	_
10-26	1949-1955	skills	abstract[91]	new[91]	_	_
10-27	1956-1959	are	_	_	_	_
10-28	1960-1963	not	_	_	_	_
10-29	1964-1970	always	object[92]	new[92]	_	_
10-30	1971-1972	a	object[92]	new[92]	_	_
10-31	1973-1983	reflection	object[92]	new[92]	_	_
10-32	1984-1986	of	object[92]	new[92]	_	_
10-33	1987-1996	knowledge	object[92]|abstract	new[92]|giv	coref	13-12[135_0]
10-34	1997-1998	,	_	_	_	_
10-35	1999-2000	a	abstract[94]	giv[94]	_	_
10-36	2001-2010	situation	abstract[94]	giv[94]	_	_
10-37	2011-2016	known	abstract[94]	giv[94]	_	_
10-38	2017-2019	as	abstract[94]	giv[94]	_	_
10-39	2020-2021	“	abstract[94]	giv[94]	_	_
10-40	2022-2028	theory	abstract[94]|abstract|abstract[97]	giv[94]|new|new[97]	_	_
10-41	2029-2030	–	abstract[94]|abstract[97]	giv[94]|new[97]	_	_
10-42	2031-2039	practice	abstract[94]|abstract|abstract[97]	giv[94]|giv|new[97]	_	_
10-43	2040-2043	gap	abstract[94]|abstract[97]	giv[94]|new[97]	_	_
10-44	2044-2045	”	abstract[94]	giv[94]	_	_
10-45	2046-2047	.	_	_	_	_

#Text=To date , the studies which have evaluated the training that healthcare students have about infectious diseases , antimicrobial resistance and safe use of antibiotics have been mainly carried out in students of medicine and pharmacy , besides students from other disciplines such as dentistry .
11-1	2048-2050	To	_	_	_	_
11-2	2051-2055	date	time	new	_	_
11-3	2056-2057	,	_	_	_	_
11-4	2058-2061	the	abstract[99]	new[99]	_	_
11-5	2062-2069	studies	abstract[99]	new[99]	_	_
11-6	2070-2075	which	abstract[99]	new[99]	_	_
11-7	2076-2080	have	abstract[99]	new[99]	_	_
11-8	2081-2090	evaluated	abstract[99]	new[99]	_	_
11-9	2091-2094	the	abstract[99]|abstract[100]	new[99]|new[100]	coref	12-46[127_100]
11-10	2095-2103	training	abstract[99]|abstract[100]	new[99]|new[100]	_	_
11-11	2104-2108	that	abstract[99]|abstract[100]	new[99]|new[100]	_	_
11-12	2109-2119	healthcare	abstract[99]|abstract[100]|organization|person[102]	new[99]|new[100]|giv|new[102]	coref	11-32[108_102]
11-13	2120-2128	students	abstract[99]|abstract[100]|person[102]	new[99]|new[100]|new[102]	_	_
11-14	2129-2133	have	abstract[99]|abstract[100]	new[99]|new[100]	_	_
11-15	2134-2139	about	abstract[99]|abstract[100]	new[99]|new[100]	_	_
11-16	2140-2150	infectious	abstract[99]|abstract[100]|abstract[103]|abstract[104]	new[99]|new[100]|giv[103]|giv[104]	coref	11-16[104_103]
11-17	2151-2159	diseases	abstract[99]|abstract[100]|abstract[103]|abstract[104]	new[99]|new[100]|giv[103]|giv[104]	_	_
11-18	2160-2161	,	abstract[99]|abstract[100]|abstract[104]	new[99]|new[100]|giv[104]	_	_
11-19	2162-2175	antimicrobial	abstract[99]|abstract[100]|abstract[104]|abstract[105]	new[99]|new[100]|giv[104]|giv[105]	coref	12-10[115_105]
11-20	2176-2186	resistance	abstract[99]|abstract[100]|abstract[104]|abstract[105]	new[99]|new[100]|giv[104]|giv[105]	_	_
11-21	2187-2190	and	abstract[99]|abstract[100]|abstract[104]	new[99]|new[100]|giv[104]	_	_
11-22	2191-2195	safe	abstract[99]|abstract[100]|abstract[104]|abstract[106]	new[99]|new[100]|giv[104]|new[106]	_	_
11-23	2196-2199	use	abstract[99]|abstract[100]|abstract[104]|abstract[106]	new[99]|new[100]|giv[104]|new[106]	_	_
11-24	2200-2202	of	abstract[99]|abstract[100]|abstract[104]|abstract[106]	new[99]|new[100]|giv[104]|new[106]	_	_
11-25	2203-2214	antibiotics	abstract[99]|abstract[100]|abstract[104]|abstract[106]|substance	new[99]|new[100]|giv[104]|new[106]|giv	coref	12-30
11-26	2215-2219	have	_	_	_	_
11-27	2220-2224	been	_	_	_	_
11-28	2225-2231	mainly	_	_	_	_
11-29	2232-2239	carried	_	_	_	_
11-30	2240-2243	out	_	_	_	_
11-31	2244-2246	in	_	_	_	_
11-32	2247-2255	students	person[108]	giv[108]	coref	11-39[111_108]
11-33	2256-2258	of	person[108]	giv[108]	_	_
11-34	2259-2267	medicine	person[108]|abstract	giv[108]|new	_	_
11-35	2268-2271	and	person[108]	giv[108]	_	_
11-36	2272-2280	pharmacy	person[108]|organization	giv[108]|new	_	_
11-37	2281-2282	,	person[108]	giv[108]	_	_
11-38	2283-2290	besides	person[108]	giv[108]	_	_
11-39	2291-2299	students	person[108]|person[111]	giv[108]|giv[111]	coref	13-13[134_111]
11-40	2300-2304	from	person[108]|person[111]	giv[108]|giv[111]	_	_
11-41	2305-2310	other	person[108]|person[111]|abstract[112]	giv[108]|giv[111]|new[112]	_	_
11-42	2311-2322	disciplines	person[108]|person[111]|abstract[112]	giv[108]|giv[111]|new[112]	_	_
11-43	2323-2327	such	person[108]|person[111]|abstract[112]	giv[108]|giv[111]|new[112]	_	_
11-44	2328-2330	as	person[108]|person[111]|abstract[112]	giv[108]|giv[111]|new[112]	_	_
11-45	2331-2340	dentistry	person[108]|person[111]|abstract[112]|abstract	giv[108]|giv[111]|new[112]|new	_	_
11-46	2341-2342	.	_	_	_	_

#Text=However , taking into account that the control of antibiotic resistance requires a multidisciplinary approach , and that nursing staff play a key role in the rational use of antibiotics , as teachers of patients , and as future drug prescribers in our country , the training of nurses could have an important impact in reducing the incidence of antibiotic resistance .
12-1	2343-2350	However	_	_	_	_
12-2	2351-2352	,	_	_	_	_
12-3	2353-2359	taking	_	_	_	_
12-4	2360-2364	into	_	_	_	_
12-5	2365-2372	account	_	_	_	_
12-6	2373-2377	that	_	_	_	_
12-7	2378-2381	the	abstract[114]	new[114]	_	_
12-8	2382-2389	control	abstract[114]	new[114]	_	_
12-9	2390-2392	of	abstract[114]	new[114]	_	_
12-10	2393-2403	antibiotic	abstract[114]|abstract[115]	new[114]|giv[115]	coref	12-60[131_115]
12-11	2404-2414	resistance	abstract[114]|abstract[115]	new[114]|giv[115]	_	_
12-12	2415-2423	requires	_	_	_	_
12-13	2424-2425	a	abstract[116]	new[116]	_	_
12-14	2426-2443	multidisciplinary	abstract[116]	new[116]	_	_
12-15	2444-2452	approach	abstract[116]	new[116]	_	_
12-16	2453-2454	,	_	_	_	_
12-17	2455-2458	and	_	_	_	_
12-18	2459-2463	that	_	_	_	_
12-19	2464-2471	nursing	person[117]	new[117]	_	_
12-20	2472-2477	staff	person[117]	new[117]	_	_
12-21	2478-2482	play	_	_	_	_
12-22	2483-2484	a	abstract[118]	new[118]	_	_
12-23	2485-2488	key	abstract[118]	new[118]	_	_
12-24	2489-2493	role	abstract[118]	new[118]	_	_
12-25	2494-2496	in	abstract[118]	new[118]	_	_
12-26	2497-2500	the	abstract[118]|event[119]	new[118]|new[119]	_	_
12-27	2501-2509	rational	abstract[118]|event[119]	new[118]|new[119]	_	_
12-28	2510-2513	use	abstract[118]|event[119]	new[118]|new[119]	_	_
12-29	2514-2516	of	abstract[118]|event[119]	new[118]|new[119]	_	_
12-30	2517-2528	antibiotics	abstract[118]|event[119]|substance	new[118]|new[119]|giv	_	_
12-31	2529-2530	,	_	_	_	_
12-32	2531-2533	as	_	_	_	_
12-33	2534-2542	teachers	person[121]	new[121]	_	_
12-34	2543-2545	of	person[121]	new[121]	_	_
12-35	2546-2554	patients	person[121]|person	new[121]|new	_	_
12-36	2555-2556	,	_	_	_	_
12-37	2557-2560	and	_	_	_	_
12-38	2561-2563	as	_	_	_	_
12-39	2564-2570	future	person[124]	new[124]	_	_
12-40	2571-2575	drug	substance|person[124]	new|new[124]	_	_
12-41	2576-2587	prescribers	person[124]	new[124]	_	_
12-42	2588-2590	in	person[124]	new[124]	_	_
12-43	2591-2594	our	person[124]|person|place[126]	new[124]|acc|new[126]	_	_
12-44	2595-2602	country	person[124]|place[126]	new[124]|new[126]	_	_
12-45	2603-2604	,	_	_	_	_
12-46	2605-2608	the	abstract[127]	giv[127]	_	_
12-47	2609-2617	training	abstract[127]	giv[127]	_	_
12-48	2618-2620	of	abstract[127]	giv[127]	_	_
12-49	2621-2627	nurses	abstract[127]|person	giv[127]|new	_	_
12-50	2628-2633	could	_	_	_	_
12-51	2634-2638	have	_	_	_	_
12-52	2639-2641	an	abstract[129]	new[129]	_	_
12-53	2642-2651	important	abstract[129]	new[129]	_	_
12-54	2652-2658	impact	abstract[129]	new[129]	_	_
12-55	2659-2661	in	abstract[129]	new[129]	_	_
12-56	2662-2670	reducing	abstract[129]	new[129]	_	_
12-57	2671-2674	the	abstract[129]|abstract[130]	new[129]|new[130]	_	_
12-58	2675-2684	incidence	abstract[129]|abstract[130]	new[129]|new[130]	_	_
12-59	2685-2687	of	abstract[129]|abstract[130]	new[129]|new[130]	_	_
12-60	2688-2698	antibiotic	abstract[129]|abstract[130]|abstract[131]	new[129]|new[130]|giv[131]	coref	13-23[0_131]
12-61	2699-2709	resistance	abstract[129]|abstract[130]|abstract[131]	new[129]|new[130]|giv[131]	_	_
12-62	2710-2711	.	_	_	_	_

#Text=Thus , the objective of this paper has been to determine the nursing students ’ knowledge and awareness of antibiotic use , resistance and stewardship .
13-1	2712-2716	Thus	_	_	_	_
13-2	2717-2718	,	_	_	_	_
13-3	2719-2722	the	abstract[132]	new[132]	_	_
13-4	2723-2732	objective	abstract[132]	new[132]	_	_
13-5	2733-2735	of	abstract[132]	new[132]	_	_
13-6	2736-2740	this	abstract[132]|abstract[133]	new[132]|new[133]	_	_
13-7	2741-2746	paper	abstract[132]|abstract[133]	new[132]|new[133]	_	_
13-8	2747-2750	has	_	_	_	_
13-9	2751-2755	been	_	_	_	_
13-10	2756-2758	to	_	_	_	_
13-11	2759-2768	determine	_	_	_	_
13-12	2769-2772	the	abstract[135]|abstract[136]	giv[135]|giv[136]	_	_
13-13	2773-2780	nursing	person[134]|abstract[135]|abstract[136]	giv[134]|giv[135]|giv[136]	_	_
13-14	2781-2789	students	person[134]|abstract[135]|abstract[136]	giv[134]|giv[135]|giv[136]	_	_
13-15	2790-2791	’	person[134]|abstract[135]|abstract[136]	giv[134]|giv[135]|giv[136]	_	_
13-16	2792-2801	knowledge	abstract[135]|abstract[136]	giv[135]|giv[136]	_	_
13-17	2802-2805	and	abstract[136]	giv[136]	_	_
13-18	2806-2815	awareness	abstract[136]|abstract[137]	giv[136]|new[137]	_	_
13-19	2816-2818	of	abstract[136]|abstract[137]	giv[136]|new[137]	_	_
13-20	2819-2829	antibiotic	abstract[136]|abstract[137]|abstract[138]	giv[136]|new[137]|new[138]	_	_
13-21	2830-2833	use	abstract[136]|abstract[137]|abstract[138]	giv[136]|new[137]|new[138]	_	_
13-22	2834-2835	,	abstract[136]|abstract[137]	giv[136]|new[137]	_	_
13-23	2836-2846	resistance	abstract[136]|abstract[137]|abstract	giv[136]|new[137]|giv	_	_
13-24	2847-2850	and	abstract[136]|abstract[137]	giv[136]|new[137]	_	_
13-25	2851-2862	stewardship	abstract[136]|abstract[137]|person	giv[136]|new[137]|new	_	_
13-26	2863-2864	.	_	_	_	_
